EW - Edwards Lifesciences Corporation
| Previous Close | 242.96 |
| Open | 245.00 |
| Bid | 238.98 x 800 |
| Ask | 241.00 x 900 |
| Day's Range | 238.78 - 245.99 |
| 52 Week Range | 139.64 - 247.64 |
| Volume | 2837845 |
| Avg. Volume | 1,091,214 |
| Market Cap | 50B |
| Beta (3Y Monthly) | 0.80 |
| PE Ratio (TTM) | 65.62 |
| EPS (TTM) | 3.64 |
| Earnings Date | Jan 29, 2020 - Feb 3, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 246.05 |
- Zacks
NuVasive (NUVA) Hits 52-Week High, Can the Run Continue?
NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks
Here's Why You Should Retain Nevro (NVRO) Stock for Now
Nevro (NVRO) is gaining traction from strengthening international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
- Zacks
Cooper Companies (COO) Q4 Earnings Beat, Revenues Rise Y/Y
Cooper (COO) gains from solid segmental contributions in fiscal fourth quarter.
- Zacks
Patterson Companies (PDCO) Q2 Earnings Surpass Estimates
Patterson Companies' (PDCO) Q2 results benefit from higher revenues, gross margin expansion and solid show by Dental segment.
- PR Newswire
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance during its annual investor conference today in New York City.
- Simply Wall St.
Here's Why I Think Edwards Lifesciences (NYSE:EW) Might Deserve Your Attention Today
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- Insider Monkey
Here’s What Hedge Funds Think About Edwards Lifesciences Corporation (EW)
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
- Zacks
What's in the Cards for Cantel Medical (CMD) in Q1 Earnings?
Better-than-expected performance at both Medical and Dental segments is likely to have driven Cantel Medical (CMD) in Q1 earnings.
- Investor's Business Daily
Why You Should Keep An Eye On These 5 Leading Health Care Stocks
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
- Zacks
Here's Why You Should Hold On to HMS Holdings (HMSY) Stock
HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services. However, high debt continues to raise concerns.
- Investor's Business Daily
50 Best ESG Companies: A List Of Today's Top Stocks For Environmental, Social And Governance Values
Finding strong stocks with solid growth needn't be a tradeoff with your environmental, social and governance values. Check out these 50 Best ESG Companies.
- Zacks
Cooper Companies (COO) to Post Q4 Earnings: What's in Store?
Better-than-expected performance at CVI and CSI, and higher revenues are likely to have aided Cooper Companies (COO) in Q4 earnings.
- Investor's Business Daily
Hot Mutual Fund Shows How 3 Heads Are Better Than 1 At Finding Top Stocks
If two heads are better than one, then surely three heads are better than two when it comes to a mutual fund's search for top growth stocks.
- Investor's Business Daily
When To Buy Stocks: Here Are 4 Places To Add Shares After A Big Winner Breaks Out
When to buy stocks at the right time? Learn key chart patterns in the best growth stocks to spot the breakout. Next, check out these follow-on entry points.
- Barrons.com
The 3 Best-Performing Health Care Stocks of 2019 So Far
The S&P 500 Health Care index has underperformed the market in 2019, up 15.2% to the S&P 500’s 25.8%. Shares of Edwards Lifesciences, which sells heart valves and monitoring equipment, are up 60.8% so far this year. In August, the Food and Drug Administration approved two Edwards devices, SAPIEN 3 and SAPIEN 3 Ultra, for a broader set of patients, following the release of positive trial results earlier in the year.
- Zacks
Edwards Lifesciences (EW) Up 6.1% Since Last Earnings Report: Can It Continue?
Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
What's in the Cards for Veeva Systems (VEEV) in Q3 Earnings?
Robust product portfolio and higher revenues are likely to have benefited Veeva Systems (VEEV) in third-quarter fiscal 2020 earnings.
- Zacks
Edwards Lifesciences, Fossil, United Airlines and Boeing highlighted as Zacks Bull and Bear of the Day
Edwards Lifesciences, Fossil, United Airlines and Boeing highlighted as Zacks Bull and Bear of the Day
- Investor's Business Daily
ESG Stocks To Consider: Here Are The Top 3 By Category
Looking for good ESG stocks to consider? This list shows those with the best stock performance ratings in their industry category, from tech to real estate.
- Investor's Business Daily
ESG Investing: Why Edwards Lifesciences Stock Is Succeeding By Just Being Itself
When it comes to ESG investing, Edwards Lifesciences stock is a leader. But the medical technology company says those standards are just core to its mission.
- Zacks
Edwards Lifesciences (EW) Recalls PASCAL's Guide Sheath
Edwards Lifesciences (EW) issues a product recall for its guide sheath based on report from its urgent field safety notice.
- Zacks
Top & Flop ETFs of Last Week
Cocoa ETF was a hot trade last week while cannabis ETF lost the most.
- Investor's Business Daily Video
Analyzing Top ESG Stocks Microsoft, Edwards Lifesciences
Finding top-performing stocks doesn't have to mean a tradeoff with environmental, social and governance values. Microsoft and Edwards Lifesciences are two top stocks that made IBD's just-released ESG 50 list. Their strong fundamentals and ESG initiatives show up in the chart action.
